* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download A Breakthrough in Understanding the Immune System Researchers
Survey
Document related concepts
Sociality and disease transmission wikipedia , lookup
Molecular mimicry wikipedia , lookup
Infection control wikipedia , lookup
Inflammation wikipedia , lookup
Sjögren syndrome wikipedia , lookup
Polyclonal B cell response wikipedia , lookup
Adaptive immune system wikipedia , lookup
Immune system wikipedia , lookup
Hospital-acquired infection wikipedia , lookup
Adoptive cell transfer wikipedia , lookup
Immunosuppressive drug wikipedia , lookup
Cancer immunotherapy wikipedia , lookup
Inflammatory bowel disease wikipedia , lookup
Innate immune system wikipedia , lookup
Transcript
BRIEFS A Biomedical Research Institute update for patients and families - who are part of discoveries in the making Winter 2011 A Breakthrough in Understanding the Immune System When we think of the relationship between a healthy immune system and the skin, we often think of white blood cells whizzing through the bloodstream to fight off an infection that is trying to penetrate the body’s surface. This conventional way of thinking was also widely accepted by the scientific community, who believed the bloodstream was the most important source of T cells, which are white blood cells capable of fighting infection. However, thanks to research at BWH, there has been a dramatic shift in how researchers believe a healthy immune system protects the skin – a breakthrough that has the potential to change the way doctors treat and cure disease. Research led by Rachael Clark, MD, PhD, and Thomas Kupper, MD, revealed that the skin of a healthy person contains approximately 20 billion T cells – two times the number found in the entire circulating blood volume. After this startling discovery, Drs. Clark and Kupper investigated why there were so many T cells in the skin and how this knowledge might be useful for treating skin cancers and other diseases. The researchers found that T cells do not simply travel through the bloodstream to the skin, fight an infection and then go away. Instead, T cells fight off the infection and then remain in the skin long term, perhaps even for a lifetime. These T cells then rapidly and effectively protect the skin when the same infection is encountered in the future. In this way, the skin accumulates a protective, immune memory. In other words, every time you get an infection, the researchers state, you vaccinate yourself against that infection. This new knowledge is helping researchers to improve vaccines and develop more effective treatments for cancer. By immunizing through the skin and tailoring cancer therapies to generate long lived, resident T cells, we can teach skin how to fight off infections and cancers. This should result in life-long protection for the skin from these challenges. Although Dr. Clark’s and Dr. Kupper’s work focuses on the skin, similar resident T cells are now being discovered in the lung and gastrointestinal tract. Because the skin is an accessible tissue in which to study human immune responses, the work of Drs. Clark and Kupper is leading the way in understanding and improving the body’s ability to fight off infections and cancers. For more information, see Dr. Clark’s review of skin resident T cells at: http:// www.ncbi.nlm.nih.gov/pmc/ar ticles/ PMC2922675/. A blood vessel from normal human skin stained for the T cell marker CD3 (red) and the immunosuppressive regulatory T cell marker FOXP3 (green). This image demonstrates that normal human skin contains a large number of T cells that can fight off infections (red cells without a green center) and a large number of regulatory T cells (red cells with a green center) that prevent autoimmunity. Researchers Study Chronic Inflammation’s Role in IBD and Colon Cancer Though not something many of us care to visualize, the human body is covered with an astonishing number and variety of microorganisms. Some of these bacteria are neither beneficial nor harmful, while others perform tasks that are useful to the body. The digestive tract has a particularly large community of bacteria, which communicate with the immune system to ward off infection and keep us healthy. Researchers have found, however, that this interaction between bacteria and the immune system is not always peaceful. In some individuals, the immune system’s reaction to bacteria in the digestive tract results in chronic gut inflammation, manifesting in conditions such as inflammatory bowel disease (IBD) and colon cancer. Research led by Wendy Garrett, MD, PhD, is looking into how this gut-to-immune system communication takes place, as well as what causes the communication to break down and lead to chronic inflammation and disease. Such questions are critical, since IBD affects (Chronic Inflammation, cont. on back) www.brighamandwomens.org/research/briefs/ Chronic Inflammation (cont.) 1.4 million people in the US in the form of Crohn’s disease and ulcerative colitis. In addition, research shows that having IBD increases your risk for developing colon cancer. So far, Dr. Garrett and her lab have found that there are different communities of bacteria within the guts of healthy mice and those sick with IBD. Furthermore, the researchers have determined that two bacte- ria in particular, which were present only in the sick mice, appear to instigate the chronic, digestive-tract inflammation associated with IBD and colon cancer. Why these bacteria exist only in sick mice, how they got there and how they work against the body’s immune system are all questions Dr. Garrett and her team hope to answer. Her lab is also focused on understanding how gut bacteria may influence the development of colon cancer. By studying the communities of bacteria in the gut and their interactions with the immune system, Dr. Garrett is hopeful that her research team and others can eventually find ways to prevent and treat IBD and colon cancer. For more information about the Garrett Lab, visit www.hsph.harvard.edu/garrettlab/. Research Literacy Acute inflammation: A normal, short-term immune Inflammation: Occurs normally when the body’s white Autoimmune disease: A type of inflammatory disorder Inflammatory Bowel Disease (IBD): A condition in response that typically appears within a few minutes or hours after an injury. It is characterized by PRISH: pain, redness, immobility (or loss of function), swelling and heat. that results from an overactive immune system and is characterized by chronic inflammation. Here, the body’s immune system triggers an immune response even though no bacteria or viruses are present, inappropriately attacking the body’s own tissue and causing damage to this tissue. Colon: The last part of the digestive system in humans. Al- though it does not play a major role in the absorption of foods and nutrients, the colon extracts water and salt from solid waste and absorbs potassium and some fat soluble vitamins. Gut: Also known as the bowel, the gut consists of the small and large intestines. It extends from the stomach to the anus. blood cells release inflammatory chemicals into the blood (i.e. when the body elicits an immune response) to protect the body from infection and foreign substances. which the large or small intestine becomes irritated and/or infected. Immune system: The body’s defense system or protection against infection and foreign substances (also called antigens) such as bacteria and viruses. It allows the body to heal from wounds and infection. T cells: A type of white blood cell that plays a central role in cell-mediated immunity. Also known as T lymphocytes, T cells have special receptors (CD3) on their cell surface. The abbreviation T, in T cell, stands for thymus, since this is the principal organ responsible for the maturation of T cells. Be Part of Discoveries in the Making Predictive, proactive, and preventive. The physicians and scientists at the Biomedical Research Institute (BRI) approach disease where it starts – at the cellular and molecular level. With a foundation of excellent clinical care, the BRI is discovering new ways to understand and treat illness. For more than a decade, BWH has ranked second in National Institutes of Health funding for independent hospitals. Our success is measured by the size and scope of our research portfolio, the dedication of our faculty and staff, and the support of our patients and families. You can join others and be part of discoveries in the making by supporting BWH research in one of several ways: sign up to receive BRIefs each season ([email protected]), make a gift through the Development Office (https:// giving.brighamandwomens.org/BRI), or volunteer to participate in a clinical trial (http://clinicaltrials.partners.org). Contact BRIefs Biomedical Research Institute Brigham and Women’s Hospital 1620 Tremont Street, 3rd Floor Boston, MA 02120 [email protected] www.brighamandwomens.org/research/ www.brighamandwomens.org/research/briefs/